about
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouseInflammation enhances resection-induced intestinal adaptive growth in IL-10 null mice.Intestinal epithelial suppressor of cytokine signaling 3 enhances microbial-induced inflammatory tumor necrosis factor-α, contributing to epithelial barrier dysfunction.Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis.Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation.Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium.Loop ileostomy-mediated fecal stream diversion is associated with microbial dysbiosis.SOC-ing it to tumors: suppressors of cytokine signaling as tumor repressors.Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli.718 Intestinal Epithelial Cell (IEC)-Specific Deletion of Suppressor of Cytokine Signaling 3 (SOCS3) in Interleukin-10 Null Mice Promotes Duodenal Tumors Independent of Inflammation: Detection with a Cathepsin-B Activatable Molecular ProbeWhat are the mechanisms of fibrosis in IBD?Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in miceCharacteristics of Intestinal Dendritic Cells in Inflammatory Bowel DiseasesHypothesis: Bacterial induced inflammation disrupts the orderly progression of the stem cell hierarchy and has a role in the pathogenesis of breast cancer
P50
Q21136177-A7A9B613-C428-4D4F-A9DA-C42CE3650D7BQ33926937-6CCEE24A-AFE2-4470-B17A-F9ABD1553E61Q34801032-B550A363-EC4C-4F77-A369-3ABC5D308B61Q37303696-040ACB4C-BB9F-4FDC-9557-B9D41AA39DE5Q40171665-6DF6909A-2582-45E4-B78A-2D7AD82B40F0Q40210981-640050E3-32F2-4DE1-B4F5-CB902F605F8FQ41661113-6F57D07F-2FE9-45C6-8E68-1E883E7BE19CQ41820315-9CFAE4A5-25E6-4ED7-971A-2DCA6CF6E4DEQ42112341-6E2F8678-5DEC-452F-B06B-3C6F3C253669Q44019660-FD6DE7D9-85F6-490E-8533-1DD1C37AD7F1Q53628008-3C942B2D-BDDF-4FDF-8541-DCE69A4117C1Q60175411-9AE7F791-FB3D-4F9C-A5E0-0D5BA2CA12C4Q60175412-F51ACF3D-5EC1-49C1-96C2-CFE42E7990FDQ60175416-1DF0FA96-3063-4E28-B6BE-700237EBD85DQ60175418-BD97C051-8638-480D-A2BC-46E7FA0A4D98Q92161511-26DD2689-8797-4638-AF42-731A7616823A
P50
description
researcher, immunology, microbiology and cancer biology
@en
wetenschapper
@nl
name
Rachael Rigby
@ast
Rachael Rigby
@en
Rachael Rigby
@es
Rachael Rigby
@nl
Rachael Rigby
@sl
type
label
Rachael Rigby
@ast
Rachael Rigby
@en
Rachael Rigby
@es
Rachael Rigby
@nl
Rachael Rigby
@sl
prefLabel
Rachael Rigby
@ast
Rachael Rigby
@en
Rachael Rigby
@es
Rachael Rigby
@nl
Rachael Rigby
@sl
P106
P2002
P21
P31
P3835
rachael-rigby
P496
0000-0002-6605-9609